C-reactive protein is elevated in obese patients with the metabolic syndrome

Diabetes Research and Clinical Practice

Volumn 71, Issue 1, 2006, Pages 92-100

  Florez, Hermes ^a,b,c,d   Castillo Florez, Sumaya ^a,c   Mendez, Armando ^a   Casanova Romero, Paul ^a,c   Larreal Urdaneta, Carmen ^a,c   Lee, David ^a   Goldberg, Ronald ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

^d DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

C reactive protein; Free fatty acids; Glucose intolerance; HOMA insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID;

ADULT; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GLUCOSE INTOLERANCE; HISPANIC; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SCREENING; SMOKING; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 29244447134     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.05.003     Document Type: Article

References (29)

1. S. Haffner, R. Valdez, and H. Hazuda Prospective analysis of the Insulin-Resistance Syndrome (Syndrome X) Diabetes 41 1992 715 722
2. B. Isomaa, P. Almgren, and T. Toumi Cardiovascular morbidity and mortality associated with the metabolic syndrome Diab Care 24 2001 683 689
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 85 (2001) 2486-2497.
4. F. Haverkate, S.G. Thompson, S.D.M. Pyke For the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Production of C-reactive protein and risk of coronary events in stable and unstable angina Lancet 349 1997 462 466
5. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men Circulation 99 1999 237 242
6. M.A. Mendall, P. Patel, and L. Ballam C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study BMJ 321 1996 1061 1065
7. R.P. Tracy, R.N. Lemaitre, and B.M. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler. Thromb. Vasc. Biol. 17 1997 1121 1127
8. J.S. Yudkin, C.D.A. Stehouver, and J.J. Emeis C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction Arterioscler. Thromb. Vasc. Biol. 19 1999 972 978
9. J.C. Pickup, M.B. Mattock, and G.D. Chusney NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 40 1997 1286 1292
10. M. Fröhlich, A. Imhof, and G. Berg Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diab. Care 23 2000 1835 1839
11. A. Festa, R. D'Agostino, and G. Howard Chronic sub-clinical inflammation as part of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS) Circulation 102 2000 42 47
12. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy American women Circulation 107 2003 391 397
13. T. Wu, J. Dorn, R. Donahue, C. Sempos, and M. Trevisan Associations of serum C-reactive protein with fasting insulin, glucose, and glycosilated hemoglobin. The Third National Health and Nutrition Examination Survey, 1988-1944 Am. J. Epidemiol. 155 2002 65 71
14. The Expert Committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diab. Care 26 (2003) 3160-3167.
15. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
16. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the San Antonio Heart Study Diab. Care 20 1997 1087 1092
17. T.A. Pearson, G.A. Mensah, and R.W. Alexander Workshop on Inflammatory Markers, and Cardiovascular Disease: application to clinical and public health practice. A statement for healthcare professionals from the Center for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
18. N. Ouchi, S. Kihara, and T. Funahashi Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
19. J. Danesh, J. Muir, and Y.K. Wong Risk factors for coronary heart disease and acute-phase proteins: a population-based study Eur. Heart J. 20 1999 954 959
20. S.A. Sakkinen, P. Wahl, M. Cushman, M.R. Lewis, and R.P. Tracy Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome Am. J. Epidemiol. 152 2000 897 907
21. I. Janssen, P.T. Katzmarzyk, and R. Ross Body mass index, waist circumference and health risk Arch. Intern. Med. 162 2002 2074 2079
22. I. Lemieux, A. Pascot, and C. Couillard Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 2000 179 184
23. J. St-Pierre, I. Lemieux, and M.C. Vohl Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease Am. J. Cardiol. 90 2002 15 18
24. I. Juhan-Vague, S.G. Thompson, and J. Jespersen Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1,500 patients with angina pectoris Arterioscler. Thromb. 13 1993 1865 1873
25. E. Barina-Mitchell, M. Cushman, E.N. Meilahn, R.P. Tracy, and L.H. Kuller Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women Am. J. Epidemiol. 153 2001 1094 1101
26. A. Pradhan, J. Manson, and N. Rifai C-reactive protein, interleukin-6, and risk of developing Type 2 diabetes mellitus JAMA 286 2001 327 334
27. T.S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E.J. Lean, and S. Haffner Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study Diab. Care 25 2002 2016 2021
28. D.J. Freeman, J. Norrie, and M.J. Caslake C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 51 2002 1596 1600
29. E.S. Ford Body mass index, diabetes, and c-reactive protein among U.S. adults Diab. Care 22 1999 1971 1977